The GIP Receptor Displays Higher Basal Activity than the GLP-1 Receptor but Does Not Recruit GRK2 or Arrestin3 Effectively

被引:38
作者
Al-Sabah, Suleiman [1 ]
Al-Fulaij, Munya [1 ]
Shaaban, Ghina [1 ]
Ahmed, Hanadi A. [1 ]
Mann, Rosalind J. [2 ]
Donnelly, Dan [2 ]
Buenemann, Moritz [3 ]
Krasel, Cornelius [3 ]
机构
[1] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait
[2] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England
[3] Univ Marburg, Inst Pharmacol & Toxicol, Sch Pharm, Marburg, Germany
基金
英国生物技术与生命科学研究理事会;
关键词
GLUCAGON-LIKE PEPTIDE-1; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; CONSTITUTIVE ACTIVITY; POLYPEPTIDE; CELLS; ACTIVATION; BETA-ARRESTIN2; IDENTIFICATION; PHYSIOLOGY;
D O I
10.1371/journal.pone.0106890
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Objectives: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are important regulators of insulin secretion, and their functional loss is an early characteristic of type 2 diabetes mellitus (T2DM). Pharmacological levels of GLP-1, but not GIP, can overcome this loss. GLP-1 and GIP exert their insulinotropic effects through their respective receptors expressed on pancreatic beta-cells. Both the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR) are members of the secretin family of G protein-coupled receptors (GPCRs) and couple positively to adenylate cyclase. We compared the signalling properties of these two receptors to gain further insight into why GLP-1, but not GIP, remains insulinotropic in T2DM patients. Methods: GLP-1R and GIPR were transiently expressed in HEK-293 cells, and basal and ligand-induced cAMP production were investigated using a cAMP-responsive luciferase reporter gene assay. Arrestin3 (Arr3) recruitment to the two receptors was investigated using enzyme fragment complementation, confocal microscopy and fluorescence resonance energy transfer (FRET). Results: GIPR displayed significantly higher (P<0.05) ligand-independent activity than GLP-1R. Arr3 displayed a robust translocation to agonist-stimulated GLP-1R but not to GIPR. These observations were confirmed in FRET experiments, in which GLP-1 stimulated the recruitment of both GPCR kinase 2 (GRK2) and Arr3 to GLP-1R. These interactions were not reversed upon agonist washout. In contrast, GIP did not stimulate recruitment of either GRK2 or Arr3 to its receptor. Interestingly, arrestin remained at the plasma membrane even after prolonged (30 min) stimulation with GLP-1. Although the GLP-1R/arrestin interaction could not be reversed by agonist washout, GLP-1R and arrestin did not co-internalise, suggesting that GLP-1R is a class A receptor with regard to arrestin binding. Conclusions: GIPR displays higher basal activity than GLP-1R but does not effectively recruit GRK2 or Arr3.
引用
收藏
页数:8
相关论文
共 37 条
[1]  
Ahrén B, 2011, DIABETES OBES METAB, V13, P158, DOI 10.1111/j.1463-1326.2011.01457.x
[2]   Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction [J].
Akhtar, Saghir ;
Yousif, Mariam H. M. ;
Dhaunsi, Gursev S. ;
Sarkhouh, Fatma ;
Chandrasekhar, Bindu ;
Attur, Sreeja ;
Benter, Ibrahim F. .
PLOS ONE, 2013, 8 (06)
[3]   Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function [J].
Al-Fulaij, Munya A. ;
Ren, Yong ;
Beinborn, Martin ;
Kopin, Alan S. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (01) :298-307
[4]   Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells [J].
Almind, K ;
Ambye, L ;
Urhammer, SA ;
Hansen, T ;
Echwald, SM ;
Holst, JJ ;
Gromada, J ;
Thorens, B ;
Pedersen, O .
DIABETOLOGIA, 1998, 41 (10) :1194-1198
[5]   An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans [J].
Amisten, Stefan ;
Salehi, Albert ;
Rorsman, Patrik ;
Jones, Peter M. ;
Persaud, Shanta J. .
PHARMACOLOGY & THERAPEUTICS, 2013, 139 (03) :359-391
[6]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[7]   Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action [J].
Campbell, Jonathan E. ;
Drucker, Daniel J. .
CELL METABOLISM, 2013, 17 (06) :819-837
[8]   Disruption of GIP/GIPR Axis in Human Adipose Tissue Is Linked to Obesity and Insulin Resistance [J].
Ceperuelo-Mallafre, Victria ;
Duran, Xavier ;
Pachon, Gisela ;
Roche, Kelly ;
Garrido-Sanchez, Lourdes ;
Vilarrasa, Nuria ;
Tinahones, Francisco J. ;
Vicente, Vicente ;
Pujol, Jordi ;
Vendrell, Joan ;
Fernandez-Veledo, Sonia .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05) :E908-E919
[9]  
Engelhardt S, 2001, MOL PHARMACOL, V60, P712
[10]   Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans [J].
Finan, Brian ;
Ma, Tao ;
Ottaway, Nickki ;
Mueller, Timo D. ;
Habegger, Kirk M. ;
Heppner, Kristy M. ;
Kirchner, Henriette ;
Holland, Jenna ;
Hembree, Jazzminn ;
Raver, Christine ;
Lockie, Sarah H. ;
Smiley, David L. ;
Gelfanov, Vasily ;
Yang, Bin ;
Hofmann, Susanna ;
Bruemmer, Dennis ;
Drucker, Daniel J. ;
Pfluger, Paul T. ;
Perez-Tilve, Diego ;
Gidda, Jaswant ;
Vignati, Louis ;
Zhang, Lianshan ;
Hauptman, Jonathan B. ;
Lau, Michele ;
Brecheisen, Mathieu ;
Uhles, Sabine ;
Riboulet, William ;
Hainaut, Emmanuelle ;
Sebokova, Elena ;
Conde-Knape, Karin ;
Konkar, Anish ;
DiMarchi, Richard D. ;
Tschoep, Matthias H. .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (209)